We supply the Australian market with leading prescription and OTC brands; including EpiPen® (adrenaline (epinephrine)) auto-injector, Bicor® (bisoprolol fumarate), Diabex® (metformin hydrochloride), Dymista® 125/50 (azelastine hydrochloride/fluticasone propionate), Noten® (atenolol), Creon® (pancreatic extract), Lipidil® (fenofibrate), Physiotens® (moxonidine) and Ferro-grad C® (ferrous sulfate, sodium ascorbate). Our branded products focus on delivering a diverse range of innovative health products and patient support services that impact people's lives on a local level.
Through the ongoing provision of our branded products and services to support specialty care, General Practice, pharmacy and consumers, we are dedicated to setting new standards in healthcare and providing the world's 7 billion people access to high quality medicine.
Our product portfolio includes a wide range of registered medications, which are indicated and TGA-approved for the treatment of several medical conditions and disease states. Key therapeutic areas consist of:
- Allergy and Anaphylaxis
- Women's Health
- Primary Care
- Metabolic Disorders
- Vaccines: Influenza